Literature DB >> 25135621

Critical periods of increased fetal vulnerability to a maternal high fat diet.

Maria del Mar Plata, Lyda Williams, Yoshinori Seki, Kirsten Hartil, Harpreet Kaur, Chia-Lei Lin, Ariana Fiallo, Alan S Glenn, Ellen B Katz, Mamta Fuloria, Maureen J Charron1, Patricia M Vuguin.   

Abstract

BACKGROUND: Fetal adaptations to high fat (HF) diet in utero (IU) that may predispose to Metabolic Syndrome (MetS) in adulthood include changes in fetal hepatic gene expression. Studies were performed to determine whether maternal exposure to HF diet at different stages during pregnancy had different effects on the fetus, including hepatic gene expression.
METHODS: Female wild type mice were fed either a HF or breeding chow (C) for 2 wks prior to mating. The experimental groups were composed of embryonic day (e) 18.5 fetuses obtained from WT female mice that were fed HF (HF, 35.5% fat) or breeding chow (C, 9.5% fat) for 2 wk before mating until e9.5 of pregnancy (periconception-midpregnancy). At e9.5 dams were switched to the opposite diet (C-HF or HF-C).
RESULTS: Exposure to HF diet throughout pregnancy reduced maternal weight gain compared to C diet (p < 0.02 HF vs. C). HF-C dams had significantly decreased adiponectin levels and litter size when compared to C-HF (p < 0.02 HF-C vs C-HF). Independent of the timing of exposure to HF, fetal weight and length were significantly decreased when compared to C diet (HF, C-HF and HF-C vs. C p < 0.02). HF diet during the second half of pregnancy increased expression of genes in the fetal liver associated with fetal growth (C-HF vs C p < 0.001), glucose production (C-HF vs C p < 0.04), oxidative stress and inflammation (C-HF vs C p < 0.01) compared to C diet.
CONCLUSIONS: This model defines that there are critical periods during gestation in which the fetus is actively shaped by the environment. Early exposure to a HF diet determines litter size while exposure to HF during the second half of pregnancy leads to dysregulation of expression of key genes responsible for fetal growth, hepatic glucose production and oxidative stress. These findings underscore the importance of future studies designed to clarify how these critical periods may influence future risk of developing MetS later in life.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25135621      PMCID: PMC4247595          DOI: 10.1186/1477-7827-12-80

Source DB:  PubMed          Journal:  Reprod Biol Endocrinol        ISSN: 1477-7827            Impact factor:   5.211


  60 in total

1.  Developmental adaptations to increased fetal nutrient demand in mouse genetic models of Igf2-mediated overgrowth.

Authors:  Emily Angiolini; Phillip M Coan; Ionel Sandovici; O H Iwajomo; Gerrard Peck; Graham J Burton; Colin P Sibley; Wolf Reik; Abigail L Fowden; Miguel Constância
Journal:  FASEB J       Date:  2011-01-31       Impact factor: 5.191

2.  Molecular characterization of insulin-mediated suppression of hepatic glucose production in vivo.

Authors:  Christopher J Ramnanan; Dale S Edgerton; Noelia Rivera; Jose Irimia-Dominguez; Ben Farmer; Doss W Neal; Margaret Lautz; E Patrick Donahue; Catalina M Meyer; Peter J Roach; Alan D Cherrington
Journal:  Diabetes       Date:  2010-02-25       Impact factor: 9.461

3.  Gestational low protein diet in the rat mediates Igf2 gene expression in male offspring via altered hepatic DNA methylation.

Authors:  Li Gong; Yuan-Xiang Pan; Hong Chen
Journal:  Epigenetics       Date:  2010-10-01       Impact factor: 4.528

4.  Diet-induced obesity model: abnormal oocytes and persistent growth abnormalities in the offspring.

Authors:  Emily S Jungheim; Erica L Schoeller; Kerri L Marquard; Erica D Louden; Jean E Schaffer; Kelle H Moley
Journal:  Endocrinology       Date:  2010-06-23       Impact factor: 4.736

Review 5.  Sirtuin 1 in lipid metabolism and obesity.

Authors:  Thaddeus T Schug; Xiaoling Li
Journal:  Ann Med       Date:  2011-02-24       Impact factor: 4.709

Review 6.  IGF1R mutations as cause of SGA.

Authors:  J Klammt; W Kiess; R Pfäffle
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2011-02       Impact factor: 4.690

Review 7.  Maternal obesity and fetal metabolic programming: a fertile epigenetic soil.

Authors:  Margaret J R Heerwagen; Melissa R Miller; Linda A Barbour; Jacob E Friedman
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-07-14       Impact factor: 3.619

8.  Insulin resistance and oxidative stress in children born small and large for gestational age.

Authors:  Valentina Chiavaroli; Cosimo Giannini; Ebe D'Adamo; Tommaso de Giorgis; Francesco Chiarelli; Angelika Mohn
Journal:  Pediatrics       Date:  2009-07-27       Impact factor: 7.124

9.  Maternal substrate utilization programs the development of the metabolic syndrome in male mice exposed to high fat in utero.

Authors:  Kirsten Hartil; Patricia M Vuguin; Michael Kruse; Esther Schmuel; Ariana Fiallo; Carlos Vargas; Matthew J Warner; Jorge L Durand; Linda A Jelicks; Maureen J Charron
Journal:  Pediatr Res       Date:  2009-10       Impact factor: 3.756

10.  Maternal high fat diet during pregnancy and lactation alters hepatic expression of insulin like growth factor-2 and key microRNAs in the adult offspring.

Authors:  Junlong Zhang; Fang Zhang; Xavier Didelot; Kimberley D Bruce; Felino R Cagampang; Manu Vatish; Mark Hanson; Hendrik Lehnert; Antonio Ceriello; Christopher D Byrne
Journal:  BMC Genomics       Date:  2009-10-16       Impact factor: 3.969

View more
  8 in total

1.  Antioxidant Effects of N-Acetylcysteine Prevent Programmed Metabolic Disease in Mice.

Authors:  Maureen J Charron; Lyda Williams; Yoshinori Seki; Xiu Quan Du; Bhagirath Chaurasia; Alan Saghatelian; Scott A Summers; Ellen B Katz; Patricia M Vuguin; Sandra E Reznik
Journal:  Diabetes       Date:  2020-05-22       Impact factor: 9.461

2.  Role of placental insufficiency and intrauterine growth restriction on the activation of fetal hepatic glucose production.

Authors:  Stephanie R Wesolowski; William W Hay
Journal:  Mol Cell Endocrinol       Date:  2015-12-23       Impact factor: 4.102

Review 3.  Oxygen radical disease in the newborn, revisited: Oxidative stress and disease in the newborn period.

Authors:  Marta Perez; Mary E Robbins; Cecilie Revhaug; Ola D Saugstad
Journal:  Free Radic Biol Med       Date:  2019-04-05       Impact factor: 7.376

4.  N-Acetylcysteine Resolves Placental Inflammatory-Vasculopathic Changes in Mice Consuming a High-Fat Diet.

Authors:  Lyda Williams; Emmanuel S Burgos; Patricia M Vuguin; Clarence R Manuel; Ryan Pekson; Swapna Munnangi; Sandra E Reznik; Maureen J Charron
Journal:  Am J Pathol       Date:  2019-08-17       Impact factor: 4.307

5.  Expression of epigenetic machinery genes is sensitive to maternal obesity and weight loss in relation to fetal growth in mice.

Authors:  Polina E Panchenko; Sarah Voisin; Mélanie Jouin; Luc Jouneau; Audrey Prézelin; Simon Lecoutre; Christophe Breton; Hélène Jammes; Claudine Junien; Anne Gabory
Journal:  Clin Epigenetics       Date:  2016-02-27       Impact factor: 6.551

6.  Maternal fructose drives placental uric acid production leading to adverse fetal outcomes.

Authors:  Zeenat A Asghar; Alysha Thompson; Maggie Chi; Andrew Cusumano; Suzanne Scheaffer; Noor Al-Hammadi; Jessica L Saben; Kelle H Moley
Journal:  Sci Rep       Date:  2016-04-29       Impact factor: 4.379

7.  Differential Effects of Post-Weaning Diet and Maternal Obesity on Mouse Liver and Brain Metabolomes.

Authors:  Sofiane Safi-Stibler; Etienne A Thévenot; Luc Jouneau; Mélanie Jouin; Alexandre Seyer; Hélène Jammes; Delphine Rousseau-Ralliard; Christine Baly; Anne Gabory
Journal:  Nutrients       Date:  2020-05-28       Impact factor: 5.717

8.  Maternal Stress Potentiates the Effect of an Inflammatory Diet in Pregnancy on Maternal Concentrations of Tumor Necrosis Factor Alpha.

Authors:  Karen L Lindsay; Claudia Buss; Pathik D Wadhwa; Sonja Entringer
Journal:  Nutrients       Date:  2018-09-06       Impact factor: 5.717

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.